Pediatric headache: A review

Pediatrics in Review

Volumn 33, Issue 12, 2012, Pages 562-576

  Blume, Heidi K ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; ANALGESIC AGENT; CALCIUM CHANNEL; CYPROHEPTADINE; GABAPENTIN; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; MAGNESIUM OXIDE; MELATONIN; METOCLOPRAMIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; ONDANSETRON; OPIATE; PARACETAMOL; POTASSIUM PUMP; PROCHLORPERAZINE; PROMETHAZINE; PROPRANOLOL; RIZATRIPTAN; SEROTONIN AGONIST; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL; ZOLMITRIPTAN;

ALCOHOL CONSUMPTION; AMNESIA; ANEMIA; ANOREXIA; ARNOLD CHIARI MALFORMATION; ATAXIA; ATRIOVENTRICULAR BLOCK; BRAIN HEMORRHAGE; BRAIN TUMOR; CARDIOVASCULAR SYSTEM; CHILD; CLUSTER HEADACHE; COGNITIVE DEFECT; DEPRESSION; DIARRHEA; DIET THERAPY; DISEASE ASSOCIATION; DIZZINESS; EATING DISORDER; EMERGENCY WARD; EPILEPSY; FATIGUE; GENE MUTATION; GENETIC SCREENING; HAIR LOSS; HEADACHE; HEART MUSCLE CONDUCTION DISTURBANCE; HEMIPLEGIC MIGRAINE; HUMAN; HYDROCEPHALUS; HYPERTENSION; HYPOTENSION; INFECTION; INFLAMMATION; INJURY; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; IRRITABILITY; LETHARGY; LEUKOPENIA; LIFESTYLE; LIVER TOXICITY; LYME DISEASE; MIGRAINE; MIGRAINE WITH AURA; MOOD DISORDER; NAUSEA; NAUSEA AND VOMITING; NEOPLASM; NEPHROLITHIASIS; NEUROIMAGING; NEUROLOGIC DISEASE; OVARY CYST; PARESTHESIA; PHONOPHOBIA; PREVALENCE; REVIEW; SARCOIDOSIS; SEDATION; SICKLE CELL ANEMIA; SIDE EFFECT; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP THERAPY; STAMEN; STOMACH PAIN; SUICIDAL BEHAVIOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TENSION HEADACHE; THROMBOCYTOPENIA; TINNITUS; TOOTH DISEASE; TRIGEMINAL AUTONOMIC CEPHALALGIA; VASCULAR DISEASE; VASCULITIC RASH; VERTIGO; VIRUS INFECTION; VIVID DREAM; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; HEADACHE; HEADACHE DISORDERS, PRIMARY; HEADACHE DISORDERS, SECONDARY; HUMANS; MEDICAL HISTORY TAKING; NEUROIMAGING; PHYSICAL EXAMINATION;

EID: 84870989924     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.33-12-562     Document Type: Review

References (26)

1. Lateef TM, Merikangas KR, He J, et al. Headache in a national sample of American children: prevalence and comorbidity. J Child Neurol. 2009;24(5):536-543
2. Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52(12):1088-1097
3. Bigal ME, Lipton RB, Winner P, Reed ML, Diamond S, Stewart WF; AMPP Advisory Group. Migraine in adolescents: association with socioeconomic status and family history. Neurology. 2007;69(1):16-25 (Pubitemid 47025200)
4. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267(1):64-69
5. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol. 1991;44(11):1147-1157
6. Rothner AD. The evaluation of headaches in children and adolescents. Semin Pediatr Neurol. 1995;2(2):109-118
7. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(suppl 1):9-160
8. Hershey AD. Current approaches to the diagnosis and management of paediatric migraine. Lancet Neurol. 2010;9(2):190-204
9. Schobitz E, Qureshi F, Lewis D. Pediatric headaches in the emergency department. Curr Pain Headache Rep. 2006;10(5):391-396 (Pubitemid 44468636)
10. Kuppermann N, Holmes JF, Dayan PS, et al Pediatric Emergency Care Applied Research Network (PECARN). Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study. Lancet. 2009;374(9696):1160-1170
11. McCrory P, Meeuwisse W, Johnston K, et al. Consensus Statement on Concussion in Sport: the 3rd International Conference on Concussion in Sport held in Zurich, November 2008. Br J Sports Med. 2009;43(suppl 1):i76-i90
12. Leddy JJ, Kozlowski K, Donnelly JP, Pendergast DR, Epstein LH, Willer B. A preliminary study of subsymptom threshold exercise training for refractory post-concussion syndrome. Clin J Sport Med. 2010;20(1):21-27
13. Ferrari A, Spaccapelo L, Gallesi D, Sternieri E. Focus on headache as an adverse reaction to drugs. J Headache Pain. 2009;10(4):235-239
14. Niebanck AE, Pollock AN, Smith-Whitley K, et al. Headache in children with sickle cell disease: prevalence and associated factors. J Pediatr. 2007;151(1):67-72, 72.e1
15. Medina LS, Pinter JD, Zurakowski D, Davis RG, Kuban K, Barnes PD. Children with headache: clinical predictors of surgical space-occupying lesions and the role of neuroimaging. Radiology. 1997;202(3):819-824 (Pubitemid 27093460)
16. Lewis DW, Ashwal S, Dahl G, et al Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002;59(4):490-498 (Pubitemid 34919980)
17. Eiland LS, Hunt MO. The use of triptans for pediatric migraines. Paediatr Drugs. 2010;12(6):379-389
18. Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44(9):885-890 (Pubitemid 39362312)
19. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50(2):466-470
20. Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003;43(6):601-610 (Pubitemid 36828795)
21. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S; American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12):2215-2224 (Pubitemid 40024327)
22. Borzy JC, Koch TK, Schimschock JR. Effectiveness of topiramate in the treatment of pediatric chronic daily headache. Pediatr Neurol. 2005;33(5):314-316 (Pubitemid 41501549)
23. Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J; Topiramate Pediatric Migraine Study Investigators. Topiramate for migraine prevention in children: a randomized, doubleblind, placebo-controlled trial. Headache. 2005;45(10):1304-1312 (Pubitemid 350004943)
24. Winner P, Gendolla A, Stayer C, et al. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. Headache. 2006;46(10):1503-1510 (Pubitemid 44722188)
25. Lewis DW. Headaches in children and adolescents. Curr Probl Pediatr Adolesc Health Care. 2007;37(6):207-246 (Pubitemid 46939671)
26. Rozen TD. New daily persistent headache: clinical perspective. Headache. 2011;51(4):641-649